Hinge Health, Inc. (HNGE)

Hinge Health Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023
Net Income	-533.24	-11.93	-108.14
Depreciation & Amortization	2.18	2.35	2.13
Other Amortization	44.57	33.51	23.84
Loss (Gain) From Sale of Investments	0.62	0.54	-10.76
Stock-Based Compensation	625.85	0.74	1.65
Provision & Write-off of Bad Debts	4.81	5.41	4.86
Other Operating Activities	2.98	4.88	13.11
Change in Accounts Receivable	-31.72	-1.34	-23.13
Change in Inventory	-6.16	0.61	10.57
Change in Accounts Payable	22.17	-10.98	11.56
Change in Unearned Revenue	89.62	77.16	35.97
Change in Other Net Operating Assets	-75.78	-51.95	-25.56
Operating Cash Flow	145.89	49	-63.91
Capital Expenditures	-0.46	-1.04	-1.98
Sale (Purchase) of Intangibles	-4.27	-2.73	-2.64
Investment in Securities	-70.45	22.09	6.12
Investing Cash Flow	-79.18	18.31	1.5
Issuance of Common Stock	256.67	0.61	0.49
Other Financing Activities	-57.67	-2.81	-3.49
Financing Cash Flow	-73.26	-2.2	-3
Net Cash Flow	-6.55	65.11	-65.41
Free Cash Flow	145.43	47.96	-65.89
Free Cash Flow Margin	27.21%	12.29%	-22.51%
Free Cash Flow Per Share	3.82	3.54	-5.06
Levered Free Cash Flow	-	73.18	-
Unlevered Free Cash Flow	-	73.18	-
Change in Working Capital	-1.87	13.5	9.41

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q